Sonoma Pharmaceuticals Inc (SNOA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $5.52M
Last updated: Nov 17, 2026 at 11:01 AM ET
Sonoma Pharmaceuticals Inc (SNOA) Earnings: Report Dates and Results
Sonoma Pharmaceuticals (SNOA) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Sonoma Pharmaceuticals reported EPS of $0.09. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
SNOA has an expected report date of Feb 8, 2027.
Earnings History
Of the 28 quarters below that had an estimate, SNOA beat 16, missed 11 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $7.17M, up 28.0% from $5.60M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 10, 2026 | $7.17M |
| Jun 30, 2026 | $0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 6, 2026 | $6.41M |
| Mar 31, 2026 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 16, 2026 | $5.56M |
| Dec 31, 2025 | -$0.48 | -$0.29 | -$0.29 - -$0.29 | -65.52% | Miss | N/A | 1 | 0 up, 0 down | Feb 10, 2026 | $4.35M |
| Sep 30, 2025 | -$0.32 | -$0.31 | -$0.31 - -$0.31 | -3.23% | Miss | N/A | 1 | 1 up, 0 down | Nov 4, 2025 | $5.60M |
| Jun 30, 2025 | -$0.37 | -$0.51 | N/A | +27.45% | Beat | N/A | N/A | 0 up, 0 down | Aug 7, 2025 | $4.01M |
| Mar 31, 2025 | -$0.48 | -$0.04 | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Jun 17, 2025 | $3.75M |
| Dec 31, 2024 | -$0.63 | -$0.60 | -$0.60 - -$0.60 | -5.00% | Miss | N/A | 1 | 0 up, 0 down | Feb 5, 2025 | $3.56M |
| Sep 30, 2024 | -$0.59 | -$0.80 | N/A | +26.25% | Beat | N/A | 1 | 0 up, 0 down | Nov 7, 2024 | $3.58M |
| Jun 30, 2024 | -$1.40 | -$0.80 | N/A | -75.00% | Miss | N/A | 1 | 0 up, 0 down | Aug 8, 2024 | $3.39M |
| Mar 31, 2024 | -$0.07 | -$0.17 | N/A | +58.82% | Beat | N/A | N/A | 0 up, 0 down | Jun 17, 2024 | $3.44M |
| Dec 31, 2023 | -$1.60 | -$4.20 | -$4.20 - -$4.20 | +61.90% | Beat | N/A | 1 | 0 up, 0 down | Feb 8, 2024 | $3.14M |
| Sep 30, 2023 | -$5.80 | -$4.80 | -$4.80 - -$4.80 | -20.83% | Miss | N/A | 1 | 0 up, 0 down | Nov 13, 2023 | $2.73M |
| Jun 30, 2023 | -$0.28 | -$0.12 | N/A | -133.00% | Miss | N/A | N/A | 0 up, 0 down | Aug 10, 2023 | $3.43M |
| Mar 31, 2023 | -$0.31 | -$0.23 | N/A | -34.78% | Miss | N/A | N/A | 0 up, 0 down | Jun 21, 2023 | $3.01M |
| Dec 31, 2022 | -$0.62 | -$0.62 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Feb 14, 2023 | $2.94M |
| Sep 30, 2022 | -$0.33 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Nov 14, 2022 | $3.33M |
| Jun 30, 2022 | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Jul 13, 2022 | $3.98M |
| Dec 31, 2021 | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Feb 11, 2022 | $2.90M |
| Sep 30, 2021 | -$0.04 | N/A | N/A | N/A | N/A | -166.7% | N/A | N/A | Nov 15, 2021 | $3.74M |
| Jun 30, 2021 | -$0.52 | N/A | N/A | N/A | N/A | -196.3% | N/A | 0 up, 0 down | Jul 14, 2021 | $3.68M |
| Mar 31, 2021 | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Jun 30, 2021 | $2.16M |
| Dec 31, 2020 | -$0.32 | -$0.72 | N/A | +55.56% | Beat | -102.5% | N/A | N/A | Feb 16, 2021 | $4.94M |
| Sep 30, 2020 | $0.06 | -$1.18 | N/A | +105.08% | Beat | N/A | N/A | N/A | Nov 20, 2020 | $5.77M |
| Jun 30, 2020 | $0.54 | -$0.91 | N/A | +159.34% | Beat | N/A | N/A | N/A | Jul 10, 2020 | $5.77M |
| Mar 31, 2020 | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2020 | $4.42M |
| Dec 31, 2019 | $12.72 | -$0.72 | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2020 | $4.39M |
| Sep 30, 2019 | -$18.20 | -$23.60 | -$23.60 - -$23.60 | +22.88% | Beat | N/A | 1 | N/A | Nov 14, 2019 | $4.73M |
| Jun 30, 2019 | -$26.70 | -$35.80 | -$35.80 - -$35.80 | +25.42% | Beat | N/A | 1 | N/A | Jul 8, 2019 | $4.38M |
| Mar 31, 2019 | -$1.52 | -$2.12 | -$2.45 - -$1.80 | +28.30% | Beat | N/A | 2 | N/A | Jun 30, 2019 | $9.58M |
| Dec 31, 2018 | -$46.80 | -$60.30 | -$82.81 - -$37.80 | +22.39% | Beat | N/A | 2 | N/A | Feb 14, 2019 | $10.32M |
| Sep 30, 2018 | -$79.20 | -$81.90 | -$99.01 - -$64.81 | +3.30% | Beat | N/A | 2 | N/A | Nov 8, 2018 | $9.57M |
| Jun 30, 2018 | -$99.00 | -$95.40 | -$95.41 - -$70.21 | -3.77% | Miss | N/A | 2 | N/A | Aug 8, 2018 | $8.46M |
| Mar 31, 2018 | -$8.37 | -$5.28 | -$5.94 - -$4.05 | -58.52% | Miss | N/A | 3 | N/A | Jun 13, 2018 | $3.65M |
| Dec 31, 2017 | -$131.40 | -$111.00 | -$113.41 - -$108.01 | -18.38% | Miss | -117.8% | 3 | N/A | Feb 7, 2018 | $4.84M |
| Sep 30, 2017 | -$120.60 | -$124.20 | N/A | +2.90% | Beat | N/A | N/A | N/A | Nov 9, 2017 | $4.33M |
| Jun 30, 2017 | -$147.60 | -$131.40 | N/A | -12.33% | Miss | N/A | N/A | N/A | Aug 8, 2017 | $3.83M |
| Mar 31, 2017 | -$5.13 | -$6.03 | N/A | +14.93% | Beat | N/A | N/A | N/A | Jun 5, 2017 | $4.03M |
| Dec 31, 2016 | $736.56 | $554.40 | N/A | +32.86% | Beat | N/A | N/A | N/A | Feb 9, 2017 | $3.36M |
| Sep 30, 2016 | -$63.72 | -$106.20 | N/A | +40.00% | Beat | N/A | N/A | N/A | Nov 10, 2016 | $2.80M |
Annual EPS
EPS for the fiscal year ended Mar 31, 2026 was -$1.32, after -$3.10 the year before. It was -$313.63 for the year ended Mar 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Mar 31, 2026 | -$1.32 | N/A |
| Mar 31, 2025 | -$3.10 | N/A |
| Mar 31, 2024 | -$7.75 | N/A |
| Mar 31, 2023 | -$2.42 | N/A |
| Mar 31, 2021 | -$0.24 | N/A |
| Mar 31, 2020 | -$32.57 | N/A |
| Mar 31, 2019 | -$226.52 | N/A |
| Mar 31, 2018 | -$407.97 | -170.9% |
| Mar 31, 2017 | $575.19 | N/A |
| Mar 31, 2016 | -$313.63 | N/A |
Frequently Asked Questions About SNOA
When is Sonoma Pharmaceuticals's next earnings date?
Sonoma Pharmaceuticals's next earnings report is expected for Feb 8, 2027.
How often does SNOA beat earnings estimates?
Sonoma Pharmaceuticals beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +3.21%.
SNOA pages: Overview, Earnings, Financials, Valuation, Competitors